Ovarian cancer

You have access
Prognostic Impact of Fascin-1 (FSCN1) in Epithelial Ovarian Cancer
LARS C. HANKER, THOMAS KARN, UWE HOLTRICH, MONIKA GRAESER, SVEN BECKER, JOSCHA REINHARD, EUGEN RUCKHÄBERLE, HEIDRUN GEVENSLEBEN and ACHIM RODY

Anticancer Research February 2013, 33 (2) 371-377;
You have access
ROS Mediate Proapoptotic and Antisurvival Activity of Oleanane Triterpenoid CDDO-Me in Ovarian Cancer Cells
XIAOHUA GAO, YONGBO LIU, DORRAH DEEB, PATRICIA LIU, ANNIE LIU, ALI S. ARBAB and SUBHASH C. GAUTAM

Anticancer Research January 2013, 33 (1) 215-221;
You have access
Utility of Mesothelin, L1CAM and Afamin as Biomarkers in Primary Ovarian Cancer
BAHRIYE AKTAS, SABINE KASIMIR-BAUER, PAULINE WIMBERGER, RAINER KIMMIG and MARTIN HEUBNER

Anticancer Research January 2013, 33 (1) 329-336;
You have access
Macrophage Migration-inhibitory Factor Levels in Serum of Patients with Ovarian Cancer Correlates with Poor Prognosis
MATHIAS KROCKENBERGER, PETER KRANKE, SEBASTIAN HÄUSLER, JÖRG BERNHARD ENGEL, EVI HORN, KATHARINA NÜRNBERGER, JÖRG WISCHHUSEN, JOHANNES DIETL and ARND HÖNIG

Anticancer Research December 2012, 32 (12) 5233-5238;
You have access
Detection of Numerical Abnormalities of Chromosome 9 and p16/CDKN2A Gene Alterations in Ovarian Cancer with Fish Analysis
CHRISTOS ARAVIDIS, ANNA D. PANANI, ZOI KOSMAIDOU, NIKOLAOS THOMAKOS, ALEXANDROS RODOLAKIS and ARISTEIDIS ANTSAKLIS

Anticancer Research December 2012, 32 (12) 5309-5313;
You have access
Studies on the Activity of Two Trans-Planaramine Platinum(II) Complexes Coded as DH4 and DH5 in Human Ovarian Tumour Models
NARJES DEQNAH, JUN Q. YU, PHILIP BEALE and FAZLUL HUQ

Anticancer Research December 2012, 32 (12) 5331-5336;
You have access
Initial Activation Status of the Antioxidant Response Determines Sensitivity to Carboplatin/Paclitaxel Treatment of Ovarian Cancer
DANIEL G. PONS, JORGE SASTRE-SERRA, MERCEDES NADAL-SERRANO, AINA OLIVER, MAGDALENA GARCÍA-BONAFÉ, ISABEL BOVER, PILAR ROCA and JORDI OLIVER

Anticancer Research November 2012, 32 (11) 4723-4728;
You have access
Epigallocatechin Gallate Acts Synergistically in Combination with Cisplatin and Designed trans-palladiums in Ovarian Cancer Cells
MOHAMMED EHSANUL HOQUE MAZUMDER, PHILIP BEALE, CHARLES CHAN, JUN Q. YU and FAZLUL HUQ

Anticancer Research November 2012, 32 (11) 4851-4860;
You have access
Uncertainty in the Utility of Immunohistochemistry in Mismatch Repair Protein Expression in Epithelial Ovarian Cancer
DOMENICO COPPOLA, SANTO V. NICOSIA, ANDREA DOTY, THOMAS A. SELLERS, JI-HYUN LEE, JIMMY FULP, ZACHARY THOMPSON, SANJA GALEB, JOHN MCLAUGHLIN, STEVEN A. NAROD, JOELLEN SCHILDKRAUT and TUYA PAL

Anticancer Research November 2012, 32 (11) 4963-4969;
You have access
siPGK1 Sensitizes Chemoresistant Human Ovarian Cancer Cell Lines to Cisplatin
CHARLOTTE LEPLEUX, EDWIGE ABEILARD-LEMOISSON, MARYLINE DUVAL, PHILIPPE ICARD and HUBERT LINCET

Anticancer Research October 2012, 32 (10) 4277-4286;

Main menu

User menu

Search

Ovarian cancer

Pages